Research
The response to therapy shows great variation among cancer patients, even when patients are diagnosed with the same type of cancer. The main reason is that no two tumors are the same; tumors are composed of many different cell types and the specific composition and functioning of a tumor affects the response to treatment. By viewing tumors as complex systems, the use of mathematical models can help to better describe and understand the relationship between composition of the tumor and its behavior. Using clinical data and knowledge of cancer biology, we develop such models to study what determines a tumor's response to treatment. These insights may help to improve cancer drugs and increase the chances of the positive response to treatment.
In our group we take a multidisciplinary and holistic approach to provide a functional understanding of drugs response in the tumor microenvironment to improve precision oncology.
Predictive biomarkers from functional analysis of static data
Spatial multicellular models
- Development of computational approaches to quantitatively characterise spatial localization of cell types in the tumor microenvironment combining imaging modalities (radiomics images, pathology slides) and molecular data. Tool: SPoTLIghT. Paper: Lapuente-Santana et al, npj Precision Oncology, 2024.
- Development of agent-based models to study how interactions between different cells in the TME coordinate tumour development and response to treatment. Models: Prostate cancer development, Prostate cancer androgen deprivation therapy. Papers: Passier et al, Cancer Research Communications, 2023, van Genderen et al, npj Systems Biology and Applications, 2024. See our cover artwork in the MathOnco newsletter.
- Training of agent-based models for specific contexts using imaging data. Paper: Wang et al, Bioinformatics, 2026.
Diagnostic and prognostic biomarkers from liquid biopsies
Mechanistic models from functional perturbation data
- Development of microfluidics technology for high-throughput perturbation screening of live cells from cancer patient biopsies. Papers: Eduati et al, Nature Communications, 2018, Yelleswarapu et al, JoVE, 2023 (including videos ).
- Inference predictive personalised mathematical models of intracellular signalling pathways based on logic ordinary differential equations to understand cellular mechanisms mediating differential drug response in patients. Tool and model: Active learning pipeline and CXCL9 model. Papers: Wang et al, Molecular Systems Biology, 2026, Eduati et al, Molecular Systems Biology, 2020.